This wiki has undergone a migration to Confluence found Here
Difference between revisions of "RPS Glossary"
Jump to navigation
Jump to search
Joelfinkle (talk | contribs) |
Joelfinkle (talk | contribs) |
||
Line 17: | Line 17: | ||
*[[Center for Food Safety and Applied Nutrition]] ([[CFSAN]]) (FDA) | *[[Center for Food Safety and Applied Nutrition]] ([[CFSAN]]) (FDA) | ||
*[[Context of Use (RPS)|Context of Use]] | *[[Context of Use (RPS)|Context of Use]] | ||
+ | *[[Correspondence (RPS)|Correspondence]] | ||
*[[Document (RPS)|Document]] | *[[Document (RPS)|Document]] | ||
*[[Document Reference (RPS)|Document Reference]] | *[[Document Reference (RPS)|Document Reference]] | ||
Line 32: | Line 33: | ||
*[[Master File Holder]] | *[[Master File Holder]] | ||
*[[Member State]] | *[[Member State]] | ||
+ | *[[Message (RPS)|Message]] | ||
*[[New Drug Application]] ([[NDA]]) | *[[New Drug Application]] ([[NDA]]) | ||
*[[Periodic Safety Update Report]] ([[PSUR]]) | *[[Periodic Safety Update Report]] ([[PSUR]]) |
Revision as of 16:32, 23 September 2008
Main Page | Regulated Clinical Research Information Management | Regulated Product Submissions | RPS Glossary
This article is under construction
Please see the RPS Glossary Documentation page for instructions for creating and editing entries.
Glossary of Abbreviations and Terms
- Abbreviated New Drug Application (ANDA)
- Annotated ECG (aECG)
- Application
- Application Number
- Approval
- Approval Unit
- Board of Health (BoH)
- Chemistry, Manufacturing and Controls (CMC)
- Center for Devices and Radiological Health (CDRH) (FDA)
- Center for Food Safety and Applied Nutrition (CFSAN) (FDA)
- Context of Use
- Correspondence
- Document
- Document Reference
- Document Relationship
- Drug Master File (DMF)
- Electrocardiogram (ECG)
- European Union (EU)
- External Electronic Source / non-retrievable
- Food and Drug Administration (FDA) (US)
- Holder of Reference Master File
- Investigational New Drug (IND)
- Investigator Brochure (IB)
- Keyword
- Master Access File
- Master File Holder
- Member State
- Message
- New Drug Application (NDA)
- Periodic Safety Update Report (PSUR)
- Phase I Meeting
- Phase II Meeting
- Post-market
- Pre-submission
- Product
- Regulated Product
- Regulated Product Submission (RPS)
- Regulatory Authority
- Reviewable Unit
- Right of Reference Request
- Sponsor
- Submission
- Submission Unit
- Supplemental New Drug Application (sNDA)
- Table of Contents (TOC)
- Threaded Discussion